Postdoctoral Scholar: Invent at Seattle Children's
- Seattle Children's
- Location: Seattle, WA
- Job Number: 7115755
- Posting Date: Nov 9, 2022
- Application Deadline: Open Until Filled
Job Description
We are now accepting applications for the Invent at Seattle Children’s Postdoctoral Scholars Program, which trains early career scientists who have been historically underrepresented in or excluded from biotech in the development of therapeutics for childhood conditions. Scholars create new “discovered here” cellular, gene or protein therapeutics that ultimately advance to clinical trials for children, all while preparing for careers in the biotech industry or in academia. Scholars will receive three years of salary starting at $70,000/year plus benefits, $10,000 in professional development funds, and protected time for coursework in entrepreneurship. Support for relocation may be available.
Possible areas of therapeutic discovery and development include gene therapy, cellular therapeutics (e.g., CAR T cells), or protein therapeutics (e.g., antibody or peptide therapeutics). Initial experiments may focus on target validation or proof-of concept efficacy studies. Later work may focus on maximizing potential therapeutic efficacy and minimizing potential toxicity. When appropriate, scholars will focus on molecules or cells that have potential to enter human clinical trials. Experiments will often involve collaboration with other scientists to create compelling data that drives subsequent research and development decisions. Scholars will engage in biotech-oriented team science that involves milestone-driven research and will collaborate with their mentors to make clear "Go/No-Go" decisions that mirror biotech mindset and processes.
For more information visit www.seattlechildrens.org/invent.
About SCRI
At the forefront of pediatric medical research, the research division at Seattle Children’s is working to cure childhood disease and improve outcomes for children all over the world. The division consists of Seattle Children’s Research Institute and Seattle Children’s Therapeutics, and is internationally recognized for its work in cancer therapies, genetics, neuroscience, immunology, infectious disease and bioethics.
Possible areas of therapeutic discovery and development include gene therapy, cellular therapeutics (e.g., CAR T cells), or protein therapeutics (e.g., antibody or peptide therapeutics). Initial experiments may focus on target validation or proof-of concept efficacy studies. Later work may focus on maximizing potential therapeutic efficacy and minimizing potential toxicity. When appropriate, scholars will focus on molecules or cells that have potential to enter human clinical trials. Experiments will often involve collaboration with other scientists to create compelling data that drives subsequent research and development decisions. Scholars will engage in biotech-oriented team science that involves milestone-driven research and will collaborate with their mentors to make clear "Go/No-Go" decisions that mirror biotech mindset and processes.
For more information visit www.seattlechildrens.org/invent.
About SCRI
At the forefront of pediatric medical research, the research division at Seattle Children’s is working to cure childhood disease and improve outcomes for children all over the world. The division consists of Seattle Children’s Research Institute and Seattle Children’s Therapeutics, and is internationally recognized for its work in cancer therapies, genetics, neuroscience, immunology, infectious disease and bioethics.
